Susquehanna International Group
JSPRW icon

Susquehanna International Group’s Japer Therapeutics Warrants JSPRW Stock Holding History

Susquehanna International Group’s Portfolio JSPRW Stock Details JSPRW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$618 Buy
+28,200
New +$911 ﹤0.01% 13040

Other funds holding JSPRW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Susquehanna International Group's JSPRW Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Japer Therapeutics Warrants (JSPRW) in Q1 2026: 28,200 shares worth $618. The stake represents ﹤0.01% of the portfolio and ranks #13040 among its holdings.

7 funds tracked by Wall St. Rank hold JSPRW as of Q1 2026.

  • Susquehanna International Group held 28,200 shares of Japer Therapeutics Warrants worth $618 as of Q1 2026.
  • Japer Therapeutics Warrants was a new Susquehanna International Group position in Q1 2026.
  • Japer Therapeutics Warrants made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #13040 holding.
  • 7 funds tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.